Thank you, Mr. Chair.
As I said initially, I'm new to this committee, so I wasn't here during the discussions on Vanessa's law, which you mentioned, Ms. Godard. The amendments that were made in 2023 broadened the provisions relating to prevention but also post-market monitoring. That's my understanding.
It's 2026 now.
In the last Parliament, a recommendation was made to provide flexibility. The members agreed but were adamant that the minister's ultimate power to order a recall not be taken away.
Here's my question. How will the bill, as it currently stands, affect the powers or latitude of Health Canada, indeed the minister? In other words, how will it affect what they can do?
